← Nippon India Mutual Fund
Nippon India Pharma Fund-Growth Plan-Growth Option
Open Ended Schemes(Equity Scheme - Sectoral/ Thematic)Very High RiskISIN INF204K01968
NAV · 06-Jul-2026
₹564.8352
1M
+6.39%
6M
+10.14%
1Y (CAGR)
+8.54%
3Y (CAGR)
+21.38%
5Y (CAGR)
+12.72%
Since inception (CAGR)
+17.75%
NAV history
hover for values
Risk & SIP analytics
Q1 · TOP · 3Y in categoryVolatility (3y)
13.03%
Downside dev (3y)
9.10%
Max drawdown (3y)
-14.8%
Sharpe (3y)
1.14
SIP XIRR (3y)
+13.85%
SIP XIRR (5y)
+17.22%
Calendar-year returns
2020 +66.4%2021 +23.9%2022 -9.9%2023 +39.1%2024 +34.0%2025 -3.3%
Fund facts
Fund managerSailesh Raj Bhan · Kinjal Desai · Amber Singhania
AUM₹86,357 Cr
TER · AMFI officialDirect 1.02% · Regular 1.86% (2026-06-30)
Launch date10-May-2004
Plan typeOpen Ended · Equity
Min lumpsumRs. 5000 and in multiples of Re.1 thereafter
Lock-inNone
Volatility17.09
AMCNippon Life India Asset Management Limited
Objective · The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.
scheme documents ↗